Diisopromine: Difference between revisions
Matt Pijoan (talk | contribs) m Protected "Diisopromine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
Rabin Bista (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{drugbox | | {{drugbox | | ||
| IUPAC_name = ''N''-(3,3-diphenylpropyl)-''N''-propan-2-yl-propan-2-amine | | IUPAC_name = ''N''-(3,3-diphenylpropyl)-''N''-propan-2-yl-propan-2-amine | ||
| image = Diisopromine.png | | image = Diisopromine Wiki Str.png | ||
| CAS_number = 5966-41-6 | | CAS_number = 5966-41-6 | ||
| ATC_prefix = A03 | | ATC_prefix = A03 | ||
| Line 24: | Line 24: | ||
| routes_of_administration = | | routes_of_administration = | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
== Overview == | |||
'''Diisopromine''' or '''disoprominum''', usually as the [[hydrochloride]] salt, is a synthetic spasmolytic which neutralizes spastic conditions of the [[biliary tract]] and of the [[sphincter of Oddi]]. It was discovered at [[Janssen Pharmaceutica]] in [[1955]]. | '''Diisopromine''' or '''disoprominum''', usually as the [[hydrochloride]] salt, is a synthetic spasmolytic which neutralizes spastic conditions of the [[biliary tract]] and of the [[sphincter of Oddi]]. It was discovered at [[Janssen Pharmaceutica]] in [[1955]]. | ||
==References== | ==References== | ||
{{Reflist|2}} | |||
* [http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=164934 Diisopromine] (NCBI, PubChem) | * [http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=164934 Diisopromine] (NCBI, PubChem) | ||
Latest revision as of 18:49, 14 April 2015
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C21H29N |
| Molar mass | 295.462 g/mol |
|
WikiDoc Resources for Diisopromine |
|
Articles |
|---|
|
Most recent articles on Diisopromine Most cited articles on Diisopromine |
|
Media |
|
Powerpoint slides on Diisopromine |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Diisopromine at Clinical Trials.gov Clinical Trials on Diisopromine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Diisopromine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Diisopromine Discussion groups on Diisopromine Patient Handouts on Diisopromine Directions to Hospitals Treating Diisopromine Risk calculators and risk factors for Diisopromine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Diisopromine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Diisopromine or disoprominum, usually as the hydrochloride salt, is a synthetic spasmolytic which neutralizes spastic conditions of the biliary tract and of the sphincter of Oddi. It was discovered at Janssen Pharmaceutica in 1955.
References
- Diisopromine (NCBI, PubChem)
Template:Pharma-stub
Template:Drugs for functional gastrointestinal disorders
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs